Oglim GP 1mg/500mg/15mg Tablet SR
Marketer
Nexkem Pharmaceuticals Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Oglim GP 1mg/500mg/15mg Tablet SR
Glycipan SR tablets (1mg/500mg/15mg) combine medications to manage blood glucose. This formulation, used alongside diet and exercise, enhances blood sugar control in adults with type 2 diabetes. It improves insulin effectiveness, reducing blood sugar. Follow your doctor's prescribed dosage and frequency; take with food to prevent stomach discomfort. If a dose is missed, take it promptly unless the next dose is imminent; avoid doubling up. Overdosing can cause dangerously low blood sugar (hypoglycemia). Concurrent use with other diabetes medication, alcohol, or skipped meals raises hypoglycemia risk; regular blood glucose monitoring is crucial. Common side effects may include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Disclose any kidney, liver, or heart conditions before starting this medication. Pregnant or lactating individuals should consult their physician. Kidney function tests will be performed prior to treatment. Limit alcohol consumption to minimize side effect risk.
Primary Ingredients of Oglim GP 1mg/500mg/15mg Tablet SR
No information provided. A rephrased version cannot be created.
Uses of Oglim GP 1mg/500mg/15mg Tablet SR
Managing type 2 diabetes
Major Benefits of Oglim GP 1mg/500mg/15mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire tablet without chewing, crushing, or breaking it. Consume the Oglim GP 1mg/500mg/15mg Extended-Release tablet with food.
Common Side effects of Oglim GP 1mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Oglim GP 1mg/500mg/15mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Oglim GP 1mg/500mg/15mg Extended-Release tablet should be taken with a meal.
How Oglim GP 1mg/500mg/15mg Tablet SR works:
Oglim GP SR tablets (1mg/500mg/15mg) combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. This triple-drug approach enhances blood glucose management when monotherapy or dual therapy proves inadequate. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin responsiveness. Finally, pioglitazone, a thiazolidinedione, further boosts insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Oglim GP 1mg/500mg/15mg SR tablets with alcohol is not recommended due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Oglim GP 1mg/500mg/15mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential benefits against any risks prior to prescribing this medication. Seek medical advice before taking this medicine.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Oglim GP 1mg/500mg/15mg tablet is likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Oglim GP 1mg/500mg/15mg SR tablets, as dose modification may be necessary. For individuals with severe kidney disease, this medication is contraindicated. Medical supervision, including regular kidney function assessments, is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Oglim GP 1mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Medical advice is necessary. Oglim GP 1mg/500mg/15mg SR tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Oglim GP 1mg/500mg/15mg Tablet SR :
Should you forget to take your Oglim GP 1mg/500mg/15mg Tablet SR, administer it at your earliest convenience. However, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take more than the prescribed dose.
Facts to Know About Oglim GP 1mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently